Validation of a Hypoglycemia Risk Stratification Tool Using Data From Continuous Glucose Monitors
- 1 March 2023
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (3), e236315
- https://doi.org/10.1001/jamanetworkopen.2023.6315
Abstract
The hypoglycemia risk stratification tool1,2 was developed to identify patients with diabetes at high risk of emergency department (ED) visits or hospitalizations due to hypoglycemia using electronic health records only. The 12-month rate of hypoglycemia-related ED visits or hospitalizations among patients at high risk was 6.7%, vs 0.3% for those at low or intermediate risk (C statistic = 0.83).1 This tool also performed well in 2 external validations among 1 350 938 patients with diabetes (C statistic = 0.79 and 0.81).1 Kaiser Permanente Northern California (KPNC) uses this tool to identify patients at high risk (those with ≥3 hypoglycemia-related ED visits or hospitalizations and insulin users with any history of hypoglycemia-related ED visits or hospitalizations). The tool is available as a free online calculator.3 To our knowledge, this tool has not been validated against biochemical hypoglycemia based on continuous glucose monitor (CGM) data.This publication has 4 references indexed in Scilit:
- Interpreting blood GLUcose data with R package igluPLOS ONE, 2021
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in RangeDiabetes Care, 2019
- Revalidation of the Hypoglycemia Risk Stratification Tool Using ICD-10 CodesDiabetes Care, 2019
- Development and Validation of a Tool to Identify Patients With Type 2 Diabetes at High Risk of Hypoglycemia-Related Emergency Department or Hospital UseJAMA Internal Medicine, 2017